KONAKION

This brand name is authorized in Australia, Austria, Croatia, Estonia, Finland, Hong Kong SAR China, Ireland, Israel, Lithuania, Malta, Netherlands, New Zealand, Singapore, South Africa, Spain, Turkey.

Active ingredients

The drug KONAKION contains one active pharmaceutical ingredient (API):

1	Phytomenadione UNII A034SE7857 - PHYTONADIONE
	The presence of vitamin K (i.e. vitamin K or substances with vitamin K activity) is essential for the formation within the body of prothrombin, factor VII, factor IX and factor X. Lack of vitamin K leads to an increased tendency to haemorrhage. When an antidote to an anticoagulant is necessary it is essential to use vitamin K1 itself, as vitamin K analogues are much less effective.
	Read more about Vitamin K1

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
KONAKION MM Solution (ampoules)	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)
KONAKION MM PAEDIATRIC Solution (ampoules)	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
B02BA01	Phytomenadione	B Blood and blood forming organs → B02 Antihemorrhagics → B02B Vitamin K and other hemostatics → B02BA Vitamin K
Discover more medicines within B02BA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	10213M
EE	Ravimiamet	1799242, 1803248, 1803350, 1803642, 1820652, 1870062
ES	Centro de información online de medicamentos de la AEMPS	008776078IP, 21610, 27262, 8776078
FI	Lääkealan turvallisuus- ja kehittämiskeskus	404939
HK	Department of Health Drug Office	30412, 38859
HR	Agencija za lijekove i medicinske proizvode	HR-H-364029156
IE	Health Products Regulatory Authority	30457, 30493
IL	מִשְׂרַד הַבְּרִיאוּת	3032, 3677
LT	Valstybinė vaistų kontrolės tarnyba	1090601, 1090602
MT	Medicines Authority	AA1411/01901, AA1456/00101, AA565/08802, AA565/08803, AA565/78201, AA729/00905
NL	Z-Index G-Standaard	13577719, 14145804
NL	Z-Index G-Standaard, PRK	48232
NZ	Medicines and Medical Devices Safety Authority	3780, 3781
SG	Health Sciences Authority	08533P, 09412P
TR	İlaç ve Tıbbi Cihaz Kurumu	8680979254035, 8680979254042
ZA	Health Products Regulatory Authority	29/22/0492